Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Autor: Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Palmerini E; Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Quagliuolo V; Department of Surgery, IRCCS Humanitas Research Hospital, Rozzano, Italy., Martin Broto J; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD, UAM), Madrid, Spain., Lopez Pousa A; Department of Cancer Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Grignani G; Department of Cancer Medicine, Ospedale Città della Scienza e della Salute, Torino, Italy., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy., Blay JY; Department of Cancer Medicine, Centre Léon Bérard Cancer Center, UNICANCER & Université Claude Bernard, Lyon, France., Tendero O; Department of Surgery, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Diaz Beveridge R; Department of Cancer Medicine, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Ferraresi V; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy., Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Centrum Onkologii, Instytutim, Marii Sklodowskiej-Curie, Warszawa, Poland., Pizzamiglio S; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fontana V; Department of Epidemiology, Clinical Trial Center, IRCCS Ospedale Policlinico San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Donati DM; Orthopaedic Oncology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Palassini E; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sanfilippo R; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchi G; Orthopaedic Oncology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Bertuzzi A; Department of Cancer Medicine, IRCCS Humanitas Research Hospital, Rozzano, Italy., Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pasquali S; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bagué S; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Coindre JM; Department of Pathology, Institut Bergonié, Bordeaux, France., Miceli R; Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dei Tos AP; Department of Pathology, University of Padua, Padova, Italy., Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 10; Vol. 42 (8), pp. 898-906. Date of Electronic Publication: 2024 Jan 17.

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Autor: Pasquali S; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Quagliuolo V; Department of Surgery, IRCCS Humanitas Research Hospital, Rozzano, Italy., Martin-Broto J; Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain.; Institute of Biomedicine of Seville, University of Seville, Seville, Spain., Lopez-Pousa A; Department of Cancer Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Grignani G; Department of Cancer Medicine, Fondazione del Piemonte per l'Oncologia IRCCS Candiolo, Turin, Italy., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto, IRCCS, Padua, Italy., Blay JY; Department of Cancer Medicine, Léon Bérard Cancer Center, Lyon, France.; Université Claude Bernard Lyon I, Lyon, France., Tendero O; Department of Surgery, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Diaz-Beveridge R; Department of Cancer Medicine, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Ferraresi V; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy., Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Centrum Onkologii Instytut im Marii Skłodowskiej Curie, Warsaw, Poland., Infante G; Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Braglia L; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Merlo DF; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Fontana V; Clinical Trial Center and Department of Epidemiology, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy., Marchesi E; Clinical Trial Center, Italian Sarcoma Group, Bologna, Italy., Donati DM; Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy., Palassini E; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchi G; Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy., Marrari A; Department of Cancer Medicine, Istituto Clinico Humanitas, Rozzano, Italy., Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bagué S; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Coindre JM; Department of Pathology, Institut Bergonié, Bordeaux, France., Dei Tos AP; Department of Pathology, Treviso General Hospital, Padua, Italy.; University of Padua, Padua, Italy., Picci P; Laboratory of Oncologic Research, Istituto Ortopedico Rizzoli, Bologna, Italy., Bruzzi P; Clinical Trial Center and Department of Epidemiology, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy., Miceli R; Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Casali PG; Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publikováno v: Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 85-93. Date of Electronic Publication: 2021 Oct 13.

FUS::DDIT3 Fusion Protein in the Development of Myxoid Liposarcoma and Possible Implications for Therapy.

Autor: Hou, Xutong¹ (AUTHOR), Shi, Wenjin¹ (AUTHOR), Luo, Wenxin¹ (AUTHOR) houxutong@stu.scu.edu.cn, Luo, Yuwen¹ (AUTHOR), Huang, Xuelin¹ (AUTHOR), Li, Jing¹ (AUTHOR), Ji, Ning¹ (AUTHOR) jining_1023@scu.edu.cn, Chen, Qianming¹ (AUTHOR)

Publikováno v: Biomolecules (2218-273X). Oct2024, Vol. 14 Issue 10, p1297. 17p.

Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios.

Autor: Samà, Laura¹ (AUTHOR) giorgia.rodda@humanitas.it, Rodda, Giorgia Amy^1,2 (AUTHOR) laura.ruspi@humanitas.it, Ruspi, Laura¹ (AUTHOR) federico.sicoli@humanitas.it, Sicoli, Federico¹ (AUTHOR) vittoria.damato@humanitas.it, D'Amato, Vittoria¹ (AUTHOR) vittorio.quagliuolo@cancercenter.humanitas.it, Renne, Salvatore Lorenzo^2,3 (AUTHOR) marta.scorsetti@hunimed.eu, Laffi, Alice⁴ (AUTHOR) alice.laffi@cancercenter.humanitas.it, Baldaccini, Davide⁵ (AUTHOR) davide.baldaccini@cancercenter.humanitas.it, Clerici, Elena⁵ (AUTHOR) elena.clerici@humanitas.it, Navarria, Pierina⁵ (AUTHOR) pierina.navarria@cancercenter.humanitas.it, Scorsetti, Marta^2,5 (AUTHOR), Bertuzzi, Alexia Francesca⁴ (AUTHOR) alexia.bertuzzi@cancercenter.humanitas.it, Quagliuolo, Vittorio Lorenzo¹ (AUTHOR) ferdinando.cananzi@hunimed.eu, Cananzi, Ferdinando Carlo Maria^1,2 (AUTHOR)

Publikováno v: Cancers. Sep2024, Vol. 16 Issue 17, p2965. 14p.

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).

Autor: Martin-Broto J; Biomedicine Institute of Seville (IBIS), Lab 215, CSIC, University of Seville, Seville, Spain jmartin@mustbesevilla.org.; Medical Oncology Department, Virgen del Rocio University Hospital, Seville, Spain., Hindi N; Biomedicine Institute of Seville (IBIS), Lab 215, CSIC, University of Seville, Seville, Spain.; Medical Oncology Department, Virgen del Rocio University Hospital, Seville, Spain., Cruz J; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Martinez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., De Sande LM; Medical Oncology Department, Hospital de León, León, Spain., Sala A; Medical Oncology Department, Hospital de Basurto, Bilbao, Spain., Bellido L; Medical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain., De Juan A; Medical Oncology Department, Hospitalario Universitario Marqués de Valdecilla, Santander, Spain., Rubió-Casadevall J; Medical Oncology Department, Hospital Josep Trueta, Instituto Catalán de Oncología, Girona, Spain., Diaz-Beveridge R; Medical Oncology Department, Hospital Universitario La Fe, Valencia, Spain., Cubedo R; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Tendero O; Department of Orthopedic Surgery, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Salinas D; Department of Orthopedic Surgery, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Gracia I; Department of Orthopedic Surgery, Hospital Universitari Sant Pau, Barcelona, Spain., Ramos R; Department of Pathology, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Baguè S; Department of Pathology, Hospital Universitari Sant Pau, Barcelona, Spain., Gutierrez A; Department of Hematology, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Duran-Moreno J; Department of Medical Oncology, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Lopez-Pousa A; Department of Medical Oncology, Hospital Universitari Sant Pau, Barcelona, Spain.

Publikováno v: The oncologist [Oncologist] 2019 Jun; Vol. 24 (6), pp. e338-e346. Date of Electronic Publication: 2018 Nov 08.